1. Home
  2. Investing
  3. Stocks
  4. USA
  6. Sarepta Therapeutics Inc New (SRPT)
  7. Quote


Sarepta Therapeutics Stock Price

0.00 (0.0%)
Volume 0
Bid Price 75.95
Ask Price 87.08
News -
Day High


52 Week Range


Day Low
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Sarepta Therapeutics Inc New SRPT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 80.81 04:00:00
Open Price Low Price High Price Close Price Prev Close
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 80.81 USD


Draw Mode:

Sarepta Therapeutics Inc New Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 7.04B 87.08M 75.32M $ 540.10M $ -406.69M -7.07 -13.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -1.62k 17.90%

more financials information »

Sarepta Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SRPT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week79.8781.8377.6980.38623,3090.941.18%
1 Month81.9592.5075.8083.68901,952-1.14-1.39%
3 Months78.29101.2475.8085.451,032,6712.523.22%
6 Months76.01101.2465.3080.98921,3754.806.31%
1 Year141.31181.8365.3088.811,255,068-60.50-42.81%
3 Years131.95181.8365.30110.181,140,488-51.14-38.76%
5 Years34.21181.8326.2685.261,402,61746.60136.22%

Sarepta Therapeutics Description

Sarepta Therapeutics is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of Sarepta's product candidates are at an early stage of development.

Your Recent History
Sarepta Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.